Trial Profile
Study of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2016
Price :
$35
*
At a glance
- Drugs Erythropoiesis stimulants (Primary) ; Trastuzumab
- Indications Breast cancer
- Focus Therapeutic Use
- 29 Jun 2016 New trial record